(Q66044279)

English

The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients

clinical trial

Statements

The Effects of Oral Nanocurcumin on Expression Levels of microRNAs and Treg Cells and Th17 Cells Development Factors in Multiple Sclerosis Patients (English)
0 references
0 references
0 references
8 June 2016
0 references
10 August 2017
0 references
41
0 references
18 year
0 references
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit